Table 3.
ω-6 PUFA Species, % |
ω-3 PUFA Species, % |
ω-6/ω-3 Ratio | |||||||
---|---|---|---|---|---|---|---|---|---|
LA | AA | DPA | Total ω-6 | ALA | EPA | DHA | Total ω-3 | ||
WT RD | 21.06 ± 0.16 | 2.55 ± 0.05 | 0.08 ± 0.00 | 23.72 ± 0.03 | 0.80 ± 0.01 | 0.17 ± 0.01 | 3.03 ± 0.02 | 4.52 ± 0.01 | 5.25 ± 0.01 |
fat-1 RD | 19.57 ± 0.63a | 0.19 ± 0.05a | 0.03 ± 0.01 | 19.85 ± 0.63a | 2.47 ± 0.17a | 0.82 ± 0.14a | 3.28 ± 0.09a | 6.74 ± 0.58a | 2.96 ± 0.28a |
WT HFD1 | 4.47 ± 0.27 | 1.57 ± 0.23 | 0.03 ± 0.01 | 6.14 ± 0.15 | 0.41 ± 0.06 | 0.10 ± 0.01 | 1.57 ± 0.11 | 2.24 ± 0.12 | 2.74 ± 0.24 |
fat-1 HFD1 | 1.86 ± 0.13a | 0.04 ± 0.01a | 0.01 ± 0.00 | 1.94 ± 0.55a | 0.73 ± 0.11a | 0.70 ± 0.15a | 2.20 ± 0.43a | 3.75 ± 0.45a | 0.52 ± 0.17a |
WT HFD2 | 21.31 ± 0.60 | 4.07 ± 0.44 | 0.16 ± 0.02 | 25.58 ± 0.55 | 0.25 ± 0.02 | 0.09 ± 0.03 | 1.62 ± 0.13 | 2.32 ± 0.13 | 11.04 ± 0.68 |
fat-1 HFD2 | 19.01 ± 0.54a | 0.18 ± 0.03a | 0.01 ± 0.00a | 19.20 ± 0.54a | 2.46 ± 0.46a | 0.94 ± 0.03a | 2.13 ± 0.13a | 6.63 ± 0.37a | 2.90 ± 0.20a |
Abbreviations: ALA, α-lipoic acid; DHA, docosahexaenoic acid; DPA, docosapentaenoic acid; LA, linoleic acid. Compositions of ω-6 or ω-3 PUFAs were expressed using relative percentages, ie, the distribution areas of ω-3 or ω-6 PUFA peaks divided by the total peak areas of all detectable saturated and unsaturated presented are means ± SD; n = 6.
P < .01 when the fat-1 group was compared with the WT control group.